Table 2.
The comparison of clinical outcomes between the control and selective retina therapy (SRT)-treated group 6 weeks after SRT.
| Control Group (n = 21) |
SRT Group (n = 22) |
p-Value | |
|---|---|---|---|
| Mean SRF height (μm) | 158.5 ± 115.8 | 79.2 ± 130.4 | 0.041 * |
| Mean CMT (μm) | 298.6 ± 91.9 | 258.2 ± 121.9 | 0.228 |
| Central choroidal thickness (μm) | 373.4 ± 71.8 | 348.1 ± 58.4 | 0.211 |
| BCVA (LogMAR) | 0.18 ± 0.14 | 0.23 ± 0.23 | 0.344 |
| Mean retinal sensitivity (DB) | 20.0 ± 4.2 | 22.3 ± 4.0 | 0.085 |
| Complete resolution rate of SRF (%) | 5/21 (23.8%) | 14/22 (63.6%) | 0.009 * |
* p < 0.05. SRF, subretinal fluid; CMT, central macular thickness.